Advertisement

Phenomenology of Ataxia

  • Steven J. FruchtEmail author
  • Pichet Termsarasab
Chapter
  • 40 Downloads

Abstract

Evaluation of patients with ataxia aims to identify patients with reversible or treatable etiologies and to secure diagnoses and improve quality of life in other patients. The movement disorder history offers important clues to the diagnosis.

Keywords

Ataxia Dysmetria Tremor Opsoclonus Ocular flutter 

Supplementary material

Video 10.1

This chapter videos cover a diverse group of patients and phenomenologies with the shared phenotype of ataxia. The videos are divided into five segments: autosomal recessive ataxias; autosomal dominant ataxias; structural ataxias; inflammatory ataxias; and paraneoplastic ataxias (MP4 8679089 kb)

References

  1. 1.
    Klockgether T, Paulson H. Milestones in ataxia. Mov Disord. 2011;26(6):1134–41.  https://doi.org/10.1002/mds.23559.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Harding AE. Introduction. In: The hereditary ataxias and related disorders. New York: Churchill Livingstone; 1984.Google Scholar
  3. 3.
    Hammond WA. A treatise on diseases of the nervous system. 7th ed. New York: D Appleton; 1881.Google Scholar
  4. 4.
    Fine EJ, Ionita CC, Lohr L. The history of the development of the cerebellar examination. Semin Neurol. 2002;22(4):375–84.  https://doi.org/10.1055/s-2002-36759.CrossRefPubMedGoogle Scholar
  5. 5.
    Barboi AC. Cerebellar ataxia. Arch Neurol. 2000;57(10):1525–7.  https://doi.org/10.1001/archneur.57.10.1525.CrossRefPubMedGoogle Scholar
  6. 6.
    Babinski J. De l’asynergie cérébelleuse. Rev Neurol (Paris). 1899;7:784.Google Scholar
  7. 7.
    Babinski J. Sur le role du cervelat dans actes volitionnels nécessitant une sucession rapide de mouvemets-diadococnésie. Rev Neurol (Paris). 1902;10:1013–5.Google Scholar
  8. 8.
    Voogd J, Koehler PJ. Historic notes on anatomic, physiologic, and clinical research on the cerebellum. Handb Clin Neurol. 2018;154:3–26.  https://doi.org/10.1016/B978-0-444-63956-1.00001-1.CrossRefPubMedGoogle Scholar
  9. 9.
    Stewart TG, Holmes G. Symptomology of cerebellar tumours; a study of 40 cases. Brain. 1904;27:522–91.CrossRefGoogle Scholar
  10. 10.
    Angel RW. The rebound phenomenon of Gordon Holmes. Arch Neurol. 1977;34(4):250.  https://doi.org/10.1001/archneur.1977.00500160064012.CrossRefPubMedGoogle Scholar
  11. 11.
    Holmes G. The symptoms of acute cerebellar injuries from gunshot wounds. Brain. 1917;40:461–535.CrossRefGoogle Scholar
  12. 12.
    Holmes G. The Croonian lectures on the clinical symptoms of cerebellar disease and their interpretation. Lecture I. Lancet. 1922;202:1178–82.Google Scholar
  13. 13.
    Holmes G. The Croonian lectures on the clinical symptoms of cerebellar disease and their interpretation. Lecture II. Lancet. 1922;202:1232–7.Google Scholar
  14. 14.
    Friedreich N. Ueber degenerative Atrophie der spinalen Hinterstränge. Virchows Arch Pathol Anat Physiol Klin Med. 1863;26:433–59.CrossRefGoogle Scholar
  15. 15.
    Friedreich N. Ueber degenerative Atrophie der spinalen Hinterstränge. Virchows Arch Pathol Anat Physiol Klin Med. 1863;26:391–419.CrossRefGoogle Scholar
  16. 16.
    Friedreich N. Ueber degenerative Atrophie der spinalen Hinterstränge. Virchows Arch Pathol Anat Physiol Klin Med. 1863;26:1–26.CrossRefGoogle Scholar
  17. 17.
    Friedreich N. Ataxie mit besonderer Berücksichtigung der hereditären Formen. Virchows Arch Pathol Anat Physiol Klin Med. 1876;68:145–245.CrossRefGoogle Scholar
  18. 18.
    Friedreich N. Ataxie mit besonderer Berücksichtigung der hereditären Formen. Nachtrag Virchows Arch Pathol Anat Physiol Klin Med. 1877;70:140–52.CrossRefGoogle Scholar
  19. 19.
    Ladame P. Friedreich’s disease. Brain. 1890;13:467–537.CrossRefGoogle Scholar
  20. 20.
    Marie P. Sur l’hérédo-ataxie cérébelleuse. Semaine médicale (Paris). 1893;13:444.Google Scholar
  21. 21.
    Holmes G. A form of familial degeneration in the cerebellum. Brain. 1907;30:466–89.CrossRefGoogle Scholar
  22. 22.
    Hayer SN, Deconinck T, Bender B, Smets K, Zuchner S, Reich S, et al. STUB1/CHIP mutations cause Gordon Holmes syndrome as part of a widespread multisystemic neurodegeneration: evidence from four novel mutations. Orphanet J Rare Dis. 2017;12(1):31.  https://doi.org/10.1186/s13023-017-0580-x.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Margolin DH, Kousi M, Chan YM, Lim ET, Schmahmann JD, Hadjivassiliou M, et al. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med. 2013;368(21):1992–2003.  https://doi.org/10.1056/NEJMoa1215993.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Synofzik M, Gonzalez MA, Lourenco CM, Coutelier M, Haack TB, Rebelo A, et al. PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain. 2014;137(Pt 1):69–77.  https://doi.org/10.1093/brain/awt326.CrossRefPubMedGoogle Scholar
  25. 25.
    Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993;4(3):221–6.  https://doi.org/10.1038/ng0793-221.CrossRefPubMedGoogle Scholar
  26. 26.
    Wadia NH, Swami RK. A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families). Brain. 1971;94(2):359–74.  https://doi.org/10.1093/brain/94.2.359.CrossRefPubMedGoogle Scholar
  27. 27.
    Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14(3):269–76.  https://doi.org/10.1038/ng1196-269.CrossRefPubMedGoogle Scholar
  28. 28.
    Holmes G. An attempt to classify cerebellar disease, with a note of Marie’s hereditary cerebellar ataxia. Brain. 1907;30:545–67.CrossRefGoogle Scholar
  29. 29.
    Bhattacharyya KB, Rai S. Joseph Godwin Greenfield: the father of neuropathology (1884-1958). Ann Indian Acad Neurol. 2015;18(3):290–1.  https://doi.org/10.4103/0972-2327.152087.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Greenfield JG. The spino-cerebellar degenerations. Charles C. Thomas: Springfield; 1954.Google Scholar
  31. 31.
    Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1(8334):1151–5.  https://doi.org/10.1016/s0140-6736(83)92879-9.CrossRefPubMedGoogle Scholar
  32. 32.
    Ashizawa T, Xia G. Ataxia. Continuum (Minneap Minn). 2016;22(4 Movement Disorders):1208–26.  https://doi.org/10.1212/CON.0000000000000362.CrossRefGoogle Scholar
  33. 33.
    Jen JC, Wan J. Episodic ataxias. Handb Clin Neurol. 2018;155:205–15.  https://doi.org/10.1016/B978-0-444-64189-2.00013-5.CrossRefPubMedGoogle Scholar
  34. 34.
    Singer HS, Mink JW, Gilbert DL, Jankovic J. Ataxia. In: Singer HS, Mink JW, Gilbert DL, Jankovic J, editors. Movement disorders in childhood. Amsterdam/Boston: Elsevier Inc.; 2016. p. 263–300.CrossRefGoogle Scholar
  35. 35.
    Ekici B, Gumus S, Ozmen M, Devecioglu O. Histiocytosis-related cerebellar leukoencephalopathy. J Pediatr Neurosci. 2011;6(2):162–3.  https://doi.org/10.4103/1817-1745.92859.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    van der Knaap MS, Arts WF, Garbern JY, Hedlund G, Winkler F, Barbosa C, et al. Cerebellar leukoencephalopathy: most likely histiocytosis-related. Neurology. 2008;71(17):1361–7.  https://doi.org/10.1212/01.wnl.0000327680.74910.93.CrossRefPubMedGoogle Scholar
  37. 37.
    Maschke M, Gomez CM, Tuite PJ, Pickett K, Konczak J. Depth perception in cerebellar and basal ganglia disease. Exp Brain Res. 2006;175(1):165–76.  https://doi.org/10.1007/s00221-006-0535-2.CrossRefPubMedGoogle Scholar
  38. 38.
    Zanni G. Head titubation: an unrecognized manifestation of Joubert syndrome and other (midline) cerebellar disorders? Dev Med Child Neurol. 2014;56(10):925–6.  https://doi.org/10.1111/dmcn.12508.CrossRefPubMedGoogle Scholar
  39. 39.
    Lu CS, Chang HC, Kuo PC, Liu YL, Wu WS, Weng YH, et al. The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family. Parkinsonism Relat Disord. 2004;10(6):369–73.  https://doi.org/10.1016/j.parkreldis.2004.03.009.CrossRefPubMedGoogle Scholar
  40. 40.
    Moro A, Munhoz RP, Arruda WO, Raskin S, Moscovich M, Teive HA. Spinocerebellar ataxia type 3: subphenotypes in a cohort of Brazilian patients. Arq Neuropsiquiatr. 2014;72(9):659–62.CrossRefGoogle Scholar
  41. 41.
    Ishikawa K, Mizusawa H, Igarashi S, Takiyama Y, Tanaka H, Ohkoshi N, et al. Pure cerebellar ataxia phenotype in Machado-Joseph disease. Neurology. 1996;46(6):1776–7.  https://doi.org/10.1212/wnl.46.6.1776.CrossRefPubMedGoogle Scholar
  42. 42.
    Kuo PH, Gan SR, Wang J, Lo RY, Figueroa KP, Tomishon D, et al. Dystonia and ataxia progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2017;45:75–80.  https://doi.org/10.1016/j.parkreldis.2017.10.007.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Pearson TS. More than Ataxia: hyperkinetic movement disorders in childhood autosomal recessive Ataxia syndromes. Tremor Other Hyperkinet Mov (N Y). 2016;6:368.  https://doi.org/10.7916/D8H70FSS.CrossRefGoogle Scholar
  44. 44.
    Park H, Kim HJ, Jeon BS. Parkinsonism in spinocerebellar ataxia. Biomed Res Int. 2015;2015:125273.  https://doi.org/10.1155/2015/125273.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Termsarasab P, Thammongkolchai T, Rucker JC, Frucht SJ. The diagnostic value of saccades in movement disorder patients: a practical guide and review. J Clin Mov Disord. 2015;2:14.  https://doi.org/10.1186/s40734-015-0025-4.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Koch M, Mostert J, Heersema D, De Keyser J. Tremor in multiple sclerosis. J Neurol. 2007;254(2):133–45.  https://doi.org/10.1007/s00415-006-0296-7.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15(3):369–91.  https://doi.org/10.1007/s12311-015-0687-3.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20.  https://doi.org/10.1212/01.wnl.0000219042.60538.92.CrossRefPubMedGoogle Scholar
  49. 49.
    Termsarasab P, Frucht S. Myoclonus. In: Louis ED, Mayer SA, Rowland LP, editors. Merritt’s neurology. 13th ed: Wolters Kluwer; 2015. p. 660–5.Google Scholar
  50. 50.
    van Gaalen J, Kerstens FG, Maas RP, Harmark L, van de Warrenburg BP. Drug-induced cerebellar ataxia: a systematic review. CNS Drugs. 2014;28(12):1139–53.  https://doi.org/10.1007/s40263-014-0200-4.CrossRefPubMedGoogle Scholar
  51. 51.
    Termsarasab P, Pitakpatapee Y, Frucht SJ, Srivanitchapoom P. Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT) presenting with pure cerebellar Ataxia. Tremor Other Hyperkinet Mov (N Y). 2018;8:585.  https://doi.org/10.7916/D8CZ4QQQ.CrossRefGoogle Scholar
  52. 52.
    Jarius S, Wildemann B. ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015;12:167.  https://doi.org/10.1186/s12974-015-0357-x.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Jarius S, Wildemann B. ‘Medusa-head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation. 2015;12:166.  https://doi.org/10.1186/s12974-015-0356-y.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Jarius S, Wildemann B. ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015;12:168.  https://doi.org/10.1186/s12974-015-0358-9.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Sedghi M, Salari M, Moslemi AR, Kariminejad A, Davis M, Goullee H, et al. Ataxia-telangiectasia-like disorder in a family deficient for MRE11A, caused by a MRE11 variant. Neurol Genet. 2018;4(6):e295.  https://doi.org/10.1212/NXG.0000000000000295.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Cortese A, Simone R, Sullivan R, Vandrovcova J, Tariq H, Yau WY, et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019;51(4):649–58.  https://doi.org/10.1038/s41588-019-0372-4.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Szmulewicz DJ, Waterston JA, Halmagyi GM, Mossman S, Chancellor AM, McLean CA, et al. Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome. Neurology. 2011;76(22):1903–10.  https://doi.org/10.1212/WNL.0b013e31821d746e.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Movement DisordersNew York University Grossman School of Medicine, The Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders, NYU Langone HealthNew YorkUSA
  2. 2.Division of Neurology, Faculty of MedicineRamathibodi Hospital, Mahidol UniversityBangkokThailand

Personalised recommendations